Allergy and infections: Long-term improvement of vernal keratoconjunctivitis following viral conjunctivitis

European Journal of Ophthalmology

Volumn 16, Issue 3, 2006, Pages 470-472

  Sgrulletta, R ^a,b   Bonini, Stefano ^a,b   Lambiase, A ^a,b   Bonini, S ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Allergic conjunctivitis; Epidemic keratoconjunctivitis; Th1; Th2; Vernal keratoconjunctivitis; Viral infection

Indexed keywords

ANTIALLERGIC AGENT; IMMUNOGLOBULIN E; STEROID;

ALLERGY; ANAMNESIS; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CLINICAL FEATURE; CYTOLOGY; DISEASE EXACERBATION; EOSINOPHIL; EYE INFLAMMATION; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MAST CELL; PHYSICAL EXAMINATION; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SCHOOL CHILD; SUPERINFECTION; TH1 CELL; TH2 CELL; VERNAL CONJUNCTIVITIS; VIRAL CONJUNCTIVITIS; VIRUS INFECTION;

EID: 33745927874     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600319     Document Type: Article

References (13)

1. Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow up. Ophthalmology 2000; 107: 1157-63.
2. Kaufman HE. Treatment of viral diseases of the cornea and external eye. Prog Retin Eye Res 2000; 19: 69-85.
3. Marsland BJ, Kopf M, Le Gros G. Viral infection and allergy. Nat Immunol 2004; 5: 865-6.
4. American Academy of Ophthalmology. Infectious diseases of external eye: clinical aspects. In: Basic and Clinical Science Course 2002-3. External Disease and Cornea. Ch. 7. San Francisco, CA: American Academy of Ophthalmology, 2003; 130-4.
5. Kanski JJ. Clinical Ophthalmology: A Systematic Approach. 5th ed. Ch. 4. Boston: Butterworth Heinemann; 2003: 68-9.
6. Maggi E, Biswas P, Del Prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991; 146: 1169-74.
7. Bonini Se, Bonini St, Lambiase A, et al. Vernal keratoconjunctivitis: a model of 5q cytokine gene cluster disease. Int Arch Allergy Immunol 1995; 107: 95-8.
8. Behera AK, Kumar M, Lockey RF, Mohapatra SS. Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther 2002; 13: 1697-709.
9. Molinier-Frenkel V, Lengagne R, Gaden F, et al. Adenovirus hexon protein is a potent adjuvant for activation cellular immune response. J Virol 2002; 76: 127-35.
10. Magone MT, Whitcup SM, Fukushima A, et al. The role of IL-12 in the induction of the late-phase cellular infiltration in a murine model of allergic conjunctivitis. J Allergy Clin Immunol 2000; 105: 299-308.
11. Fukushima A, Fukata K, Ozaki A, et al. Exertion of the suppressive effects of IFN-γ on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br J Ophthalmol 2002; 86: 1166-71.
12. Stern M, Siemasko K, Gao J, et al. Role of interferon-γ in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2005; 46: 3239-46.
13. Matricardi PM, Bonini S. Mimicking microbial "education" of the immune system: a strategy to revert the epidemic trend of atopy and allergic asthma? Respir Res 2000; 1: 129-32.